Application 210339
- Type
- ANDA
- Sponsor
- SINOTHERAPEUTICS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PROPAFENONE HYDROCHLORIDE | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 225MG | No | No |
| 002 | PROPAFENONE HYDROCHLORIDE | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 325MG | No | No |
| 003 | PROPAFENONE HYDROCHLORIDE | PROPAFENONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 425MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69680-130 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |
| 69680-130 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |
| 69680-131 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |
| 69680-131 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |
| 69680-132 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |
| 69680-132 | Propafenone Hydrochloride | propafenone | Vitruvias Therapeutics | ANDA | Current |